MENU
INSM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Insmed (INSM) Ownership - Who owns Insmed?
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
700 US Highway 202/206
Phone
+1 908 977-9900
Employees
912
Web
https://www.insmed.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
20.65B
P/E Ratio
N/A
Total Cash
1.2B
Projected Growth
N/A
Total Debt
1.14B
Revenue
381.03M
Risk (Beta)
1.16
Dividend Yield
N/A
Total Cash/Share
6.31
Total Debt/Equity
15.03
Revenue/Share
2.21 USD as % of share price
Fundamentals
INSM
Capitalization
20.6B
P/E Ratio
N/A
Risk (Beta)
1.16
Dividend Yield
N/A
Total Cash
1.2B
Total Cash/Share
6.31
Total Debt
1.14B
Total Debt/Equity
15.03
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.21%
Revenue
381M
ROE
N/A
Book Value
99.2M
P/B Ratio
208.33
Cash Flow
N/A
Earnings
-5.93
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.82M
Current Ratio
5.86
Current Revenue Per Employee
73031.47
Dividends Per Share - Security
N/A
EBITDA
-917.87M
Float
N/A
Float - Current
N/A
Gross Income Margin
77.08
Revenue To Assets
-68.42
Shares Held By Institutions
28.2B
Shares Outstanding - Current
190M
Total Liabilities
1.7B
Total Volume MTD
N/A
Value
-1
Gain YTD
57.430
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
700 US Highway 202/206
Phone
+1 908 977-9900
Employees
912
Web
https://www.insmed.com